A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Seto, Wai Kay ^a   Lee, Chun Fan ^b,c   Lai, Ching Lung ^a   Ip, Philip P C ^a   Fong, Daniel Yee Tak ^a   Fung, James ^a   Wong, Danny Ka Ho ^a   Yuen, Man Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B(E) ANTIGEN; SERUM ALBUMIN; VIRUS DNA;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; APGA INDEX; APRI INDEX; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FIB-4 INDEX; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; ISHAK FIBROSIS SCORE; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PAPAS INDEX; PREDICTIVE VALUE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY; THROMBOCYTE COUNT; TRAINING; VALIDATION STUDY; VIRUS LOAD; ADOLESCENT; BIOLOGICAL MODEL; LIVER CIRRHOSIS; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; AREA UNDER CURVE; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; YOUNG ADULT;

EID: 80051604371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023077     Document Type: Article

References (48)

1. Lai CL, Yuen MF, (2007) The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann Intern Med 147: 58-61.
2. Chen CJ, Yang HI, Su J, Jen CL, You SL, et al. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
3. Yuen MF, Yuan HJ, Wong DK, Yuen JC, Wong WM, et al. (2005) Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 54: 1610-1614.
4. Iloeje UH, Yang HI, Su J, Jen CL, You SL, et al. (2006) Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130: 678-686.
5. Lok AS, McMahon BJ, (2009) Chronic hepatitis B: update 2009. Hepatology 50: 661-662.
6. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, et al. (2008) Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2: 263-283.
7. Piccinino F, Sagnelli E, Pasquale G, Giusti G, (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2: 165-173.
8. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, (2009) Liver biopsy. Hepatology 49: 1017-1044.
9. Abdi W, Millan JC, Mezey E, (1979) Sampling variability on percutaneous liver biopsy. Arch Intern Med 139: 667-669.
10. ter Borg F, ten Kate FJ, Cuypers HT, Leentvaar-Kuijpers A, Oosting J, et al. (2000) A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals. J Clin Pathol 53: 541-548.
11. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97: 2614-2618.
12. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526.
13. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, et al. (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43: 1317-1325.
14. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, et al. (2001) Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357: 1069-1075.
15. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, et al. (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36: 986-992.
16. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, et al. (2005) Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51: 1867-1873.
17. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, et al. (2007) FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 45: 297-306.
18. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, et al. (2003) Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 39: 222-230.
19. Wai CT, Cheng CL, Wee A, Dan YY, Chan E, et al. (2006) Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int 26: 666-672.
20. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, et al. (2005) Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology 42: 1437-1445.
21. Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, et al. (2005) Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 100: 616-623.
22. Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, et al. (2006) Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol 101: 2537-2545.
23. Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, et al. (2007) Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 27: 969-976.
24. Fung J, Lai CL, Fong DY, Yuen JC, Wong DK, et al. (2008) Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver Int 28: 1408-1416.
25. Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, et al. (2005) A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42: 1373-1381.
26. Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, et al. (2005) Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol 5: 32.
27. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, et al. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431-435.
28. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699.
29. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, et al. (2002) Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137: 1-10.
30. Mehta SH, Lau B, Afdhal NH, Thomas DL, (2009) Exceeding the limits of liver histology markers. J Hepatol 50: 36-41.
31. Castera L, Pinzani M, (2010) Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59: 861-866.
32. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, et al. (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128: 343-350.
33. Castera L, Sebastiani G, Le Bail B, de Ledinghen V, Couzigou P, et al. (2010) Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol 52: 191-198.
34. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, et al. (2003) A comparison of fibrosis progression in chronic liver diseases. J Hepatol 38: 257-265.
35. Fung J, Lai CL, But D, Wong D, Cheung TK, et al. (2008) Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management. Am J Gastroenterol 103: 1421-1426.
36. Kamimoto Y, Horiuchi S, Tanase S, Morino Y, (1985) Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology 5: 367-375.
37. Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R, et al. (2001) Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol 113: 590-595.
38. Chu CJ, Hussain M, Lok AS, (2002) Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 36: 1408-1415.
39. Freed MN, Ryan JM, Hess RK, (1991) Handbook of Statistical Procedures and Their Computer Applications to Education and the Behavioral Sciences New York American Council on Education and Macmillan Publishing Company.
40. Edirisooriya G, (1995) Stepwise Regression Is a Problem, Not a Solution. Education Resources Information Center (ERIC; http://www.eric.ed.gov): ED393890.
41. Welge P, (1990) Three Reasons Why Stepwise Regression Methods Should Not Be Used by Researchers. Education Resources Information Center (ERIC; http://www.eric.ed.gov): ED316583.
42. Park MY, Hastie T, (2007) L1-regularization path algorithm for generalized linear models. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 69: 659-677.
43. Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, et al. (2008) Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 70: 191-199.
44. Guo W, Lin S, (2009) Generalized linear modeling with regularization for detecting common disease rare haplotype association. Genetic Epidemiology 33: 308-316.
45. Parkman HP, Jacobs M, Mishra AK, Kramarczyk J, Gaughan J, et al. (2010) W1392 DNA Microarray SNP Analysis of Domperidone Efficacy in Patients With Gastroparesis. Gastroenterology 138: S-714.
46. Fung J, Lai CL, Cheng C, Wu R, Wong DK, et al. (2011) Mild-to-Moderate Elevation of Alanine Aminotransferase Increases Liver Stiffness Measurement by Transient Elastography in Patients With Chronic Hepatitis B. Am J Gastroenterol 106 (3): 492-496.
47. Wong GLH, Wong VWS, Choi PCL, Chan AWH, Chan HLY, (2010) Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. Alimentary Pharmacology & Therapeutics 31: 1095-1103.
48. Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, et al. (2009) SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 49: 1821-1827.